Richard Jenkins

Richard serves as Chief Growth Officer at Aetion, a New York-based healthcare technology company that provides real-world evidence solutions for life sciences, payers, and regulatory agencies. Formerly the global head of Real-World and Late Phase Business Development with IQVIA, Richard was responsible for developing and leading go-to-market strategy for IQVIA’s Real-World Insights business. Richard joined IQVIA (Quintiles) through the acquisition of Outcome Sciences where he led the global business development team for Outcome Sciences. From 2006-2008, Richard was the vice president, Global Business Development of ArisGlobal, a SaaS business selling solutions into the life sciences industry. Prior to joining ArisGlobal, Richard spent seven years with IntraLinks, an online secure platform supporting information for clinical trials, M&A due diligence, and syndicated financing. He played a critical role in transitioning the core customer base from financial services and legal to key stakeholders across the life sciences industry.